Hsbc Holdings PLC cut its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 11.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,354,768 shares of the company’s stock after selling 178,269 shares during the period. Hsbc Holdings PLC’s holdings in Corteva were worth $90,950,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of the company. JPL Wealth Management LLC purchased a new stake in Corteva in the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva during the 4th quarter worth approximately $27,000. Bank of Jackson Hole Trust purchased a new position in Corteva during the 4th quarter worth approximately $28,000. Cornerstone Financial Management LLC acquired a new stake in Corteva during the 4th quarter valued at approximately $29,000. Finally, Basepoint Wealth LLC acquired a new stake in Corteva during the 4th quarter valued at approximately $30,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on CTVA shares. Jefferies Financial Group increased their price objective on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. UBS Group decreased their target price on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research report on Tuesday, June 9th. Argus upped their price target on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, March 31st. Berenberg Bank increased their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. Finally, Royal Bank Of Canada lifted their price objective on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.81.
Corteva Price Performance
NYSE:CTVA opened at $78.57 on Monday. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $52.55 billion, a PE ratio of 46.22, a price-to-earnings-growth ratio of 2.40 and a beta of 0.57. The stock’s 50-day moving average price is $79.64 and its 200-day moving average price is $75.76.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is 42.35%.
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Recommended Stories
- Five stocks we like better than Corteva
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
